$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

SARS-CoV-2 neutralizing antibody development strategies 원문보기

Turkish journal of biology = Türk biyoloji dergisi, v.44 no.3, 2020년, pp.203 - 214  

BALCIOĞLU, Bertan Koray (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) ,  DENİZCİ (Bİ) ,  ÖNCÜ, Melis (TAK, Kocaeli Turkey) ,  ÖZTÜRK, Hasan Ümit (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) ,  YÜCEL, Fatıma (Bİ) ,  KAYA, Filiz (TAK, Kocaeli Turkey) ,  SERHATLI, Müge (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) ,  ÜLBEĞİ (Bİ) ,  POLAT, Hivda (TAK, Kocaeli Turkey) ,  TEKİN, Şaban (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) ,  ÖZDEMİR BAHADIR, Aylin (Bİ)

Abstract AI-Helper 아이콘AI-Helper

In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health Organization (WHO) described the most recent cor...

주제어

참고문헌 (88)

  1. Ahmadzadeh V Farajnia S Feizi MA Nejad RA 2014 Antibody humanization methods for development of therapeutic applications Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 33 67 24746146 

  2. Akamatsu Y Pakabunto K Xu Z Zhang Y Tsurushita N 2007 Whole IgG surface display on mammalian cells: application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies Journal of Immunological Methods 327 40 17719061 

  3. Bahadir AO Balcioglu BK Uzyol KS Hatipoglu I Sogut I 2011 Phage displayed HBV core antigen with immunogenic activity Applied Biochemistry and Biotechnology 165 1437 21915589 

  4. Barnard DL Day CW Bailey K Heiner M Montgomery R 2006 Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice Antiviral Chemistry and Chemotherapy 17 275 17176632 

  5. BerryJ D Jones S Drebot MA Andonov A Sabara M 2004 Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus Journal of Virological Methods 120 87 15234813 

  6. Bisht H Roberts A Vogel L Bukreyev A Collins PL 2004 Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Proceedings of the National Academy of Sciences of the United States of America 101 6641 15096611 

  7. Casadevall A Pirofski LA 2020 The convalescent sera option for containing COVID-19 Journal of Clinical Investigation 130 1545 32167489 

  8. Carmen S Jermutus L 2002 Concepts in antibody phage display Briefings in Functional Genomics and Proteomics 1 189 15239904 

  9. Chen L Xiong J Bao L Shi Y 2020 Convalescent plasma as a potential therapy for COVID-19. The Lancet Infectious Diseases 20 398 32113510 

  10. Chen Z Zhang L Qin C Ba L Yi CE 2005 Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region Journal of Virology 79 2678 15708987 

  11. Cheong WS Leow CY Majeed ABA Leow CH 2020 Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody International Journal of Biological Macromolecules 147 369 31926922 

  12. Davey RT Dodd L Proschan MA Neaton J Nordwall JN 2016 The PREVAIL II Writing Group, for the Multi-National PREVAIL II Study Team ( New England Journal of Medicine 375 1448 27732819 

  13. King DJ Bowers PM Kehry MR Horlick RA 2014 Mammalian cell display and somatic hypermutation in vitro for human antibody discovery Current Drug Discovery Technologies 11 56 23978037 

  14. Day CW Baric R Cai SX Frieman M Kumaki Y 2009 A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo Virology 395 210 19853271 

  15. Duan K Liu B Li C Zhang H Yu T 2020 Effectiveness of convalescent plasma therapy in severe Covid-19 patients Proceedings of the National Academy of Sciences 117 9490 

  16. Erdag B Balcioglu KB Kumbasar A Celikbicak O Zeder-Lutz G 2007 Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity Molecular Biotechnology 35 51 17401149 

  17. Erdag B Balcioglu BK Bahadir AO Serhatli M Kacar O 2011 Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2 Biotechnology and Applied Biochemistry 58 412 22172104 

  18. Ertekin O Guloglu FB Pirincci S Tuglu S Akcael E 2013 Antibody based systems for the determination of mycotoxins in food and feed Current Opinion in Biotechnology 24 (Supplement 1 23 23 

  19. Folgori A Tafi R Meola A Felici F Galfre G 1994 A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera The EMBO Journal 13 2236 7514533 

  20. Fuentes M Palomo JM Mateo C Venteo A Sanz A 2005 Optimization of the modification of carrier proteins with aminated haptens Journal of Immunological Methods 307 144 16263130 

  21. Galfre G Milstein C Part B 1982 Preparation of monoclonal antibodies: strategies and procedures Methods in Enzymology 73 3 

  22. Glass WG Subbarao K Murphy B Murphy PM 2004 Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARSCoV) pulmonary infection of mice The Journal of Immunology 173 4030 15356152 

  23. Gorny MK 2012 Human Hybridoma Technology Antibody Technology Journal 2 1 

  24. Greenough TC Carville A Coderre J Somasundaran M Sullivan JL 2005 Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus American Journal of Pathology 167 455 16049331 

  25. Ho M Nagata S Pastan I 2006 Isolation of anti-CD22 Fv with high affinity by Fv display on human cells Proceedings of the National Academy of Sciences 103 9637 

  26. Ho M Pastan I Totowa 2009 Display and selection of scFv antibodies on HEK-293T cells Antibody Phage Display. Methods in Molecular Biology (Methods and Protocols) 562 99 

  27. Hogan RJ Gao G Rowe T Bell P Flieder D 2004 Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1 Journal of Virology 78 11416 15452265 

  28. Huang J Doria-Rose NA Longo NS Laub L Lin C-L 2013 Isolation of human monoclonal antibodies from peripheral blood B cells Nature Protocols 8 1907 24030440 

  29. Iannolo G Minenkova O Petruzzelli R Cesareni G 1995 Modifying filamentous phage capsid: limits in the size of the major capsid protein Journal of Molecular Biology 248 835 7752244 

  30. Ju B Zhang Q Ge X Wang R Yu J 2020 Potent human neutralizing antibodies elicited by SARS-CoV-2 infection 10 

  31. Klasse PJ 2014 Neutralization of virus iInfectivity by antibodies: old problems in new perspectives Advances in Biology 157895 157895 27099867 

  32. Kim JH Hong HJ 2012 Humanization by CDR grafting and specificity-determining residue grafting Methods in Molecular Biology 907 237 22907355 

  33. Kowalski M Guindon J Brazas L Moore C Entwistle J 2012 A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guerin The Journal of Urology 188 1712 22998907 

  34. Kuiken T Fouchier RA Schutten M Rimmelzwaan GF Van Amerongen G 2003 Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Lancet 362 263 12892955 

  35. Lawler JV Endy TP Hensley LE Garrison A Fritz EA 2006 Cynomolgus macaque as an animal model for severe acute respiratory syndrome PLoS Medicine 3 e149 e149 16605302 

  36. Ledsgaard L Kilstrup M Karatt-Vellatt A McCafferty J Laustsen AH 2018 Basics of antibody phage display technology Toxins 10 236 236 

  37. Li H Liu SM Yu XH Tang SL Tang CK 2020 Coronavirus disease 2019 (COVID-19): current status and future perspectives International Journal of Antimicrobial Agents 105951 105951 32234466 

  38. Li J Sai M Berger M Chao Q Davidson D 2006 Human antibodies for immunotherapy development generated via a human B cell hybridoma technology Proceedings of the National Academy of Sciences of the United States of America 103 3557 16505368 

  39. Li K McCray PB 2020 ( Methods in Molecular Biology 161 

  40. Lim CC Woo PCY Lim TS 2019 Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies Scientific Reports 9 6088 6088 30988390 

  41. Liu X Gao F Gou L Chen Y Gu Y 2020 Neutralizing antibodies isolated by a site-directed screening have potent protection on SARS-CoV-2 infection 10 

  42. Luke T Wu H Zhao J Channappanavar R Coleman CM 2016 Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo Science Translational Medicine 8 326ra21 326ra21 

  43. Martina BE Haagmans BL Kuiken T Fouchier RA Rimmelzwaan GF 2003 Virology: SARS virus infection of cats and ferrets Nature 425 915 915 14586458 

  44. McAuliffe J Vogel L Roberts A Fahle G Fischer S 2004 Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys Virology 330 8 15527829 

  45. McCafferty J Griffiths AD Winter G Chiswell DJ 1990 Phage antibodies: filamentous phage displaying antibody variable domains Nature 348 552 2247164 

  46. McCray PB Pewe L Wohlford-Lenane C Hickey M Manzel L 2007 Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus Journal of Virology 81 813 17079315 

  47. Mimmi S Maisano D Quinto I Iaccino E 2019 Phage display: an overview in context to drug discovery Trends in Pharmacological Sciences 40 87 30606501 

  48. Nancy T Janine T Nancy T Janine T 2004 Bacteriophages Australia: Blackwell Science Ltd 105 

  49. Omar N Lim TS Hust M Totowa 2018 Construction of Naive and Immune Human Fab Phage-Display Library Phage Display. Methods in Molecular Biology 1701 25 29116498 

  50. Kaye M Druce J Tran T Kostecki R Chibo D 2006 SARS-associated coronavirus replication in cell lines Emerging Infectious Diseases 12 128 16494729 

  51. Qin C Wang J Wei Q She M Marasco WA 2005 An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus Journal of Pathology 206 251 15892035 

  52. Ratnam S Gadag R West R Burris J Oates E 1995 Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody Journal of Clinical Microbiology 33 811 7790442 

  53. Roberts A Paddock C Vogel L Butler E Zaki S 2005a Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans Journal of Virology 79 5833 15827197 

  54. Roberts A Vogel L Guarner J Hayes N Murphy B 2005b Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Journal of Virology 79 503 15596843 

  55. Roberts A Deming D Paddock CD Cheng A Yount B 2007 A mouse adapted SARS-coronavirus causes disease and mortality in BALB/C mice PLoS Pathogens 3 e5 e5 17222058 

  56. Roberts A Lamirande EW Vogel L Jackson JP Paddock CD 2008 Animal models and vaccines for SARS-CoV infection Virus Research 133 20 17499378 

  57. Beerli BB Bauer M Buser RB Gwerder M Muntwiler S 2008 Isolation of human monoclonal antibodies by mammalian cell display Proceedings of the National Academy of Sciences of the United States of America 105 14336 18812621 

  58. Rowe T Gao G Hogan RJ Crystal RG Voss TG 2004 Macaque model for severe acute respiratory syndrome Journal of Virology 78 11401 15452262 

  59. Safdari Y Farajnia S Asgharzadeh M Khalili M 2013 Antibody humanization methods - a review and update Biotechnology and Genetic Engineering Reviews 29 175 24568279 

  60. Shanehbandi D Majidi J Kazemi T Baradaran B Aghebati-Maleki L 2017 Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody Human Antibodies 26 1 28269762 

  61. Shen C Wang Z Zhao F Yang Y Li J 2015 Treatment of critically ill patients with COVID-19 with convalescent plasma JAMA 323 1582 

  62. Shernan SK Fitch JC Nussmeier NA Chen JC Rollins SA 2004 Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass The Annals of Thoracic Surgery 77 942 14992903 

  63. Schmidt NJ Dennis J Lennette EH 1976 Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells Journal of Clinical Microbiology 4 61 182716 

  64. Shukra AM Sridevi NV Dev C Kapil M 2014 Production of recombinant antibodies using bacteriophages European Journal of Microbiology and Immunology 4 91 24883194 

  65. Scott AS Crowe JE 2015 Use of human hybridoma technology to isolate human monoclonal antibodies Microbiology Spectrum 3 

  66. Siu YL Teoh KT Lo J Chan CM Kien F 2008 The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles Journal of Virology 82 11318 18753196 

  67. Stephen JT Nisalak A Anderson KB Libraty DH Kalayanarooj S 2009 Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance The American Journal of Tropical Medicine and Hygiene 81 825 19861618 

  68. Smith GP 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 1228 1315 

  69. Smith GP Petrenko VA 1997 Phage Display. Chemical Reviews 97 391 11848876 

  70. Subbarao K McAuliffe J Vogel L Fahle G Fischer S 2004 Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice Journal of Virology 78 3572 15016880 

  71. Ter Meulen J Bakker AB Van den Brink EN Weverling GJ Martina BE 2004 Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Lancet 363 2139 15220038 

  72. Traggiai E Becker S Subbaro K Kolesnikova L Uematsu Y 2004 An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Nature Medicine 10 871 

  73. Waldmann H Totowa 2014 Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity Human Monoclonal Antibodies, Methods and Protocols. Methods in Molecular Biology 1060 1 

  74. Wan Y Shang J Sun S Tai W Chen J 2020 Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry Journal of Virology 94 19 19 

  75. Wang C Li W Drabek D Okba NMA Haperen R 2020 A human monoclonal antibody blocking SARS-CoV-2 infection Nature Communications 11 2251 2251 

  76. Widjaja I Wang C Van Haperen R Gutierrez-Alvarez J Van Dieren 2019 Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein Emerging Microbes and Infections 8 516 30938227 

  77. Wilson PC Andrews SF 2012 Tools to therapeutically harness the human antibody response Nature Reviews Immunology 12 709 

  78. Wong SK Li W Moore MJ Choe H Farzan M 2004 A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 Journal of Biological Chemistry 279 3197 14670965 

  79. Wrapp D Wang N Corbett KS Goldsmith JA Hsieh CL 2020a Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science 13 1260 

  80. Wrapp D De Vlieger D Corbett KS Torres GM Breedam WV 2020 Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies Cell 181 1 32243785 

  81. Wu F Wang A Liu M Wang Q Chen J 2020 Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications MedRxiv. 

  82. 2020 doi: 10 

  83. Wu Y Li C Xia S Tian X Kong Y 2020 Identification of human single-domain antibodies against SARS-CoV-2 Cell Host and Microbe 27 1 31951820 

  84. Xiong H Wu J Cao J Yang R Ma J 2020 Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells BioRxiv (preprint) 

  85. Zeng X Lingfang Li Lin Jing Li Xinlei 2020 Isolation of a human monoclonal antibody specific for the receptor-binding domain of SARS-CoV-2 using a competitive phage biopanning strategy Antibody Therapeutics 3 95 

  86. Zhao G He L Sun S Qiu H Tai W Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity A Novel 2018 Protective Efficacy against MERS-CoV Journal of Virology 92 18 18 

  87. Zhou P Yang XL Wang XG Hu B Zhang L 2020 A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270 32015507 

  88. Zhou C Jacobsen FW Cai L Chen Q Shen D 2020 Development of a novel mammalian cell surface antibody display platform mAbs 2 508 518 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로